Evidence map›Paper›PMID 32935912›Full record

ArticleJournal of biomedical materials research. Part B, Applied biomaterials2021

Protecting the skin-implant interface with transcutaneous silver-coated skin-and-bone-integrated pylon in pig and rabbit dorsum models.

Maxim Shevtsov, Dmitriy Gavrilov, Natalia Yudintceva, Elena Zemtsova, Andrei Arbenin, Vladimir Smirnov, Irina Voronkina, Polina Adamova, Miralda Blinova, Nataliya Mikhailova and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of biomedical materials research. Part B, Applied biomaterials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 3 countries.

Maxim ShevtsovDepartment of Radiation Immuno-Oncology, Center for Translational Cancer Research Technische Universität München (TranslaTUM), Klinikum Rechts der Isar, Munich, Germany.ORCID 0000-0002-8539-2239
Dmitriy GavrilovFederal State Budgetary Institution "Federal Scientific Center of Rehabilitation of the Disabled named after G.A. Albrecht" of the Ministry of Labour and Social Protection of the Russian Federation, St. Petersburg, Russia.
Natalia YudintcevaCenter of Cell Technologies, Institute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg, Russia.ORCID 0000-0002-7357-1571
Elena ZemtsovaDepartment of Solid State Chemistry, Saint Petersburg State University, St. Petersburg, Russia.
Andrei ArbeninDepartment of Solid State Chemistry, Saint Petersburg State University, St. Petersburg, Russia.
Vladimir SmirnovDepartment of Solid State Chemistry, Saint Petersburg State University, St. Petersburg, Russia.
Irina VoronkinaInstitute of Experimental Medicine, St. Petersburg, Russia.
Polina AdamovaInstitute of Experimental Medicine, St. Petersburg, Russia.
Miralda BlinovaCenter of Cell Technologies, Institute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg, Russia.
Nataliya MikhailovaCenter of Cell Technologies, Institute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg, Russia.
Oleg GalibinDepartment of Biotechnology, First Pavlov State Medical University of St.Petersburg, St. Petersburg, Russia.
Michael AkkaouiTanury Industries, Lincoln, Rhode Island, USA.
Mark PitkinTufts University, Boston, Massachusetts, USA.
Institute of Cytology · RUSt Petersburg University · RUInstitute of Experimental Medicine · RUFar Eastern Federal University · RUFederal Scientific Center for the Rehabilitation of the Disabled by G.A. Albrecht of the Ministry of Labor and Social Protection of the Russian Federation · RUFirst Pavlov State Medical University of St. Petersburg · RUKVH Industries (United States) · USTufts University · US

Funding

Validating establishment of functional safety in skin interface with deeply porous transcutaneous pylon for direct skeletal attachment of limb prosthesesR44AR079960 · NIAMS · POLY-ORTH INTERNATIONAL · PI PITKIN, MARK · 2021 to 2022
$1.7M
Large animal study on deeply porous transcutaneous pylon for direct skeletal attachmentR44HD090768 · NICHD · POLY-ORTH INTERNATIONAL · PI PITKIN, MARK · 2016 to 2017
$1.4M
Manufacturing technology for skin integrated composite prosthetic pylonR44HD057492 · NICHD · POLY-ORTH INTERNATIONAL · PI PITKIN, MARK · 2009 to 2010
$750k
Manufacturing technology for skin integrated composite prosthetic pylonR43HD057492 · NICHD · POLY-ORTH INTERNATIONAL · PI PITKIN, MARK · 2007 to 2007
$97k
NIAMS NIH HHS R44 AR079960NICHD NIH HHS R43 HD057492NICHD NIH HHS R44 HD057492NICHD NIH HHS R44 HD090768NIH HHS HD057492NIH HHS HD090768
6 · The paper itself

Abstract

Implant-associated soft tissue infections at the skin-implant interface represent the most frequent complications in reconstructive surgery and lead to implant failures and revisions. Titanium implants with deep porosity, called skin-and-bone-integrated-pylons (SBIP), allow for skin ingrowth in the morphologically natural direction, thus restoring a reliable dermal barrier and reducing the risk of infection. Silver coating of the SBIP implant surface using physical vapor deposition technique offers the possibility of preventing biofilm formation and exerting a direct antimicrobial effect during the wound healing phase. In vivo studies employing pig and rabbit dorsum models for assessment of skin ingrowth into the pores of the pylon demonstrated the safety of transcutaneous implantation of the SBIP system. No postoperative complications were reported at the end of the follow-up period of 6 months. Histological analysis proved skin ingrowth in the minipig model without signs of silver toxicity. Analysis of silver release (using energy dispersive X-ray spectroscopy) in the model of intramedullary-inserted silver-coated SBIP in New Zealand rabbits demonstrated trace amounts of silver after 3 months of in-bone implantation. In conclusion, selected temporary silver coating of the SBIP implant surface is powerful at preventing the periprosthetic infections without imparing skin ingrowth and can be considered for clinical application.

Indexed as

Coated Materials, BiocompatibleImplants, ExperimentalWound HealingAbsorbable ImplantsAnimalsMaleMaterials TestingMatrix MetalloproteinasesMicroscopy, Electron, ScanningOsseointegrationPorosityProsthesis DesignRabbitsSilverSkinSoft Tissue InfectionsCoated Materials, BiocompatibleMatrix MetalloproteinasesSilverTitaniumimplantsosseointegrationsilver coatingskin-and-bone-integrated-pylonskin-implant interface

Identifiers

PMID32935912
PMCPMC9317244
OpenAlexW3087323803

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.